Browsing: Obesity

Want to learn about the latest advances in obesity management? In this exclusive dialogue, two renowned experts: Prof. David E. Cummings, Endocrinologist and Professor of Medicine at the
University of Washington, internationally recognised for his pioneering research on the hormonal and metabolic mechanisms regulating appetite, body weight and glucose homeostasis and Dr.
Tham Kwang Wei, Senior Consultant Endocrinologist and Chairperson of the Singapore Association for the Study of Obesity (SASO), address current unmet needs in obesity
management. Bridging the gap between medical and surgical approaches, they explored how the Dual Incretin Receptor Agonist – Tirzepatide, is redefining patient care and transforming
obesity treatment management landscape.

Log In or Register as a healthcare professional to read the full article.

Struggling with belly fat after 40? Hormones, muscle loss, slower metabolism, stress and poor sleep can all reshape the midlife waistline. Here is why it happens and what you can realistically do.

Novo Nordisk launches Wegovy in China, targeting the country’s 180 million people with obesity. Priced at ¥1,400 ($192 USD) per starter dose, it faces accessibility challenges as it’s not covered by national insurance. The move heightens competition with Eli Lilly.

From lifestyle changes and diet adjustments to medications and minimally invasive procedures, diverse weight loss options are available to help individuals achieve lasting health goals.

The study utilised data from 115,726 participants enrolled in the Health Examinees (HEXA) study. The study is a component of the larger Korean Genome and Epidemiology Study. It is aimed at exploring the risk factors for chronic diseases among adults over 40 in Korea. Researchers assessed the participants’ dietary intake through a food frequency questionnaire, including their consumption of various types of kimchi. They analysed the relationship between kimchi intake, body mass index (BMI), and waist circumference.